Number
|
Response AHB
|
Response CHB
|
K
D
|
Reference
|
---|
HBsEC-1
|
14/23
|
N/A
|
N/A
|
[13]
|
HBsEC-2
|
6/13
|
1/15
|
N/A
|
[9, 14]
|
HBsEC-3
|
N/A
|
16/17
|
N/A
|
[8]
|
HBsEC-4
|
42/56
|
5/33
|
N/A
|
[6, 8, 9, 14, 15]
|
HBsEC-5
|
2/4
|
0/12
|
N/A
|
[14]
|
HBsCP-6
| | |
<50 nM
| |
HBsCP-7
| | |
<50 nM
| |
HBsCP-8
| | |
<50 nM
| |
HBsCP-9
| | |
<50 nM
| |
HBsCP-10
| | |
>500 nM
| |
HBcEC-11
|
41/59
|
9/30
|
50–10,000 nM
|
[6, 8, 9, 14–17]
|
HBcEC-12
|
N/A
|
1/1
|
N/A
|
[18]
|
HBcEC-13
|
N/A
|
2/5
|
>50 nM
|
[8]
|
HBcEC-14
|
7/12
|
0/11
|
>500 nM
|
[19]
|
HBcEC-15
|
N/A
|
15/18
|
>50 nM
|
[8]
|
HBcCP-16
| | |
<50 nM
| |
HBcCP-17
| | |
>500 nM
| |
HBcCP-18
| | |
<50 nM
| |
HBcCP-19
| | |
<50 nM
| |
HBcCP-20
| | |
50–500 nM
| |
- All K
D values are in silico predictions by NetMHC version 3.2 8mer predictions. HBsEC: HBsAg experimentally confirmed; HBsCP: HBsAg computer predicted; HBcEC: HBcAg experimentally confirmed; HBcCP: HBcAg computer predicted. N/A: Not available, AHB and CHB referres to number of responders in previous studies of acute hepatitis B (AHB) and chronic hepatitis B patients (CHB)